LVTX β€” LAVA THERAPEUTICS

Ownership history in TSFG, LLC  Β·  17 quarters on record

This page tracks every 13F SEC filing in which TSFG, LLC reported a position in LAVA THERAPEUTICS (LVTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

% of Fund (quarterly)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 400 β€” 0% 0.00% $1K β€”
2025 Q2 UNCHANGED 400 β€” 0% 0.00% $1K β€”
2025 Q1 UNCHANGED 400 β€” 0% 0.00% $1K β€”
2024 Q3 UNCHANGED 400 β€” 0% 0.00% $1K β€”
2024 Q2 UNCHANGED 400 β€” 0% 0.00% $1K β€”
2024 Q1 UNCHANGED 400 β€” 0% 0.00% $1K β€”
2023 Q4 UNCHANGED 400 β€” 0% 0.00% $1K β€”
2023 Q3 UNCHANGED 400 β€” 0% 0.00% $1K β€”
2023 Q2 UNCHANGED 400 β€” 0% 0.00% $1K β€”
2023 Q1 UNCHANGED 400 β€” 0% 0.00% $1K β€”
7 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding LVTX

As of 2025 Q3 β€” sorted by position size

BML Capital Management, LLC 3Y 2.81% Shay Capital LLC 3Y 0.34% Redmile Group, LLC 3Y 7Y 0.31% Rangeley Capital, LLC 0.22% GTS SECURITIES LLC 0.01% EQUITEC PROPRIETARY MARKETS, LLC 3Y 7Y 0.01% EQUITEC PROPRIETARY MARKETS, LLC 3Y 7Y 0.0% JBF Capital, Inc. 3Y 7Y 0.0% TORNO CAPITAL, LLC 0.0% XTX Topco Ltd 3Y 0.0%
← Back to TSFG, LLC Holdings